ArticleInternational journal of molecular medicine2018

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.

Dongdong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.